30 Years working to identify, prevent and treat HIV/AIDS

June 5 marks the 30th year that U.S. public health agencies have been engaged in the war against HIV/AIDS, and GRA university partner Emory University has been a world leader in the fight.  From inventing some of the most successful HIV/AIDS drugs, to developing and testing promising vaccines, conducting clinical trials, leading behavioral and prevention research and treating thousands of patients, Emory has played a key role.

GRA has invested significantly in winning the battle against this killer of more than 30 million worldwide through recruiting several of the most prominent AIDS researchers; by helping to develop the Emory Vaccine Center, the Emory Center for AIDS Research and the University of Georgia Center for Drug Discovery; by providing sophisticated research tools; and by fostering the growth of GeoVax, a Georgia company in Phase II clinical trials for a promising HIV/AIDS vaccine.

The war is far from over, but progress toward victory is being made, in no small part through the efforts of Georgia’s research universities.

Read more here and here.